A detailed history of Tanaka Capital Management Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Tanaka Capital Management Inc holds 153,291 shares of CPRX stock, worth $3.24 Million. This represents 7.05% of its overall portfolio holdings.

Number of Shares
153,291
Previous 153,391 0.07%
Holding current value
$3.24 Million
Previous $2.38 Million 28.24%
% of portfolio
7.05%
Previous 5.62%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$15.19 - $21.35 $1,519 - $2,135
-100 Reduced 0.07%
153,291 $3.05 Million
Q1 2024

May 15, 2024

SELL
$13.18 - $17.11 $13,707 - $17,794
-1,040 Reduced 0.67%
153,391 $2.45 Million
Q4 2023

Feb 14, 2024

SELL
$11.78 - $17.29 $63,140 - $92,674
-5,360 Reduced 3.35%
154,431 $2.6 Million
Q2 2023

Aug 14, 2023

BUY
$11.5 - $18.08 $132,365 - $208,100
11,510 Added 7.76%
159,791 $2.15 Million
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $345,728 - $760,014
-48,970 Reduced 24.83%
148,281 $1.9 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $68,143 - $93,738
-10,938 Reduced 5.25%
197,251 $1.38 Million
Q1 2022

May 16, 2022

SELL
$5.31 - $8.31 $28,780 - $45,040
-5,420 Reduced 2.54%
208,189 $1.73 Million
Q4 2021

Feb 14, 2022

BUY
$5.21 - $7.45 $54,861 - $78,448
10,530 Added 5.19%
213,609 $1.45 Million
Q3 2021

Nov 15, 2021

BUY
$4.85 - $6.04 $145,500 - $181,200
30,000 Added 17.33%
203,079 $1.08 Million
Q2 2021

Aug 13, 2021

SELL
$4.29 - $6.05 $221,771 - $312,754
-51,695 Reduced 23.0%
173,079 $995,000
Q1 2021

May 17, 2021

SELL
$3.45 - $4.69 $1,725 - $2,345
-500 Reduced 0.22%
224,774 $1.04 Million
Q4 2020

Feb 11, 2021

SELL
$2.97 - $3.83 $79,967 - $103,122
-26,925 Reduced 10.68%
225,274 $752,000
Q3 2020

Nov 13, 2020

SELL
$2.97 - $5.08 $92,946 - $158,978
-31,295 Reduced 11.04%
252,199 $749,000
Q2 2020

Aug 17, 2020

BUY
$3.48 - $5.05 $19,905 - $28,886
5,720 Added 2.06%
283,494 $1.31 Million
Q1 2020

May 15, 2020

SELL
$2.61 - $5.21 $12,136 - $24,226
-4,650 Reduced 1.65%
277,774 $1.07 Million
Q4 2019

Feb 14, 2020

SELL
$3.67 - $5.7 $3,339 - $5,187
-910 Reduced 0.32%
282,424 $1.06 Million
Q3 2019

Nov 15, 2019

BUY
$3.89 - $7.43 $224,647 - $429,082
57,750 Added 25.6%
283,334 $1.51 Million
Q2 2019

Aug 15, 2019

SELL
$2.7 - $6.11 $22,167 - $50,163
-8,210 Reduced 3.51%
225,584 $866,000
Q1 2019

May 16, 2019

SELL
$2.11 - $5.33 $35,635 - $90,018
-16,889 Reduced 6.74%
233,794 $1.19 Million
Q2 2018

Aug 16, 2018

SELL
$2.26 - $3.84 $13,356 - $22,694
-5,910 Reduced 2.3%
250,683 $782,000
Q4 2017

Feb 16, 2018

BUY
$2.51 - $4.4 $38,942 - $68,266
15,515 Added 6.44%
256,593 $1 Million
Q3 2017

Nov 16, 2017

BUY
$2.4 - $2.94 $578,587 - $708,769
241,078
241,078 $608,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.17B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Tanaka Capital Management Inc Portfolio

Follow Tanaka Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanaka Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tanaka Capital Management Inc with notifications on news.